Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep;52(9):983-6.

Antibody titers for canine parvovirus type-2, canine distemper virus, and canine adenovirus type-1 in adult household dogs

Masayuki Taguchi  1 , Kazuhiko Namikawa, Takuya Maruo, Kensuke Orito, Jonathan Lynch, Hiroeki Sahara
Affiliations

Antibody titers for canine parvovirus type-2, canine distemper virus, and canine adenovirus type-1 in adult household dogs

Masayuki Taguchi et al. Can Vet J. 2011 Sep.

Abstract
in English, French

Serum antibody titers for canine parvovirus type-2 (CPV-2), canine distemper virus (CDV) and canine adenovirus type-1 (CAV-1) were investigated in 1031 healthy adult household dogs (2 to 18 years old) given an annual inoculation in the previous 11 to 13 months. The number of dogs retaining significant titers of antibodies against CPV-2, CDV, and CAV-1 were 888 (86%), 744 (72%), and 732 (71%), respectively. There were no differences between males and females in antibody titers against the 3 viruses. Antibody titer for CPV-2 was significantly higher in younger dogs than in older dogs, CDV antibody was significantly higher in older dogs than in younger dogs, and CAV titer was not associated with age.

Taux d’anticorps anti-parvovirus canin de type 2, anti-virus de la maladie de Carré et anti-adénovirus canin de type 1, chez les chiens de compagnie adultes. Les taux de rétention d’anticorps sériques de la parvovirose canine (CPV-2), de la maladie de Carré (CDV) et de l’encéphalite de Rubarth — type-1 (CAV-1) ont été mesurés chez 1031 chiens de compagnie adultes en bonne santé. Les nombres de chiens ayant un taux conséquent d’anticorps CPV-2, CDV et CAV-1 ont été respectivement de 888 (86 %) de 744 (72 %) et de 732 (71 %). Nous n’avons pas noté de différence sexuelle significative pour les taux d’anticorps CPV-2, CDV et CAV-1. Par groupe d’âge les taux d’anticorps CPV-2 sont plus élevés de façon significative chez les jeunes chiens que chez les chiens plus âgés, et ceux de CDV sont significativement plus élevés chez les chiens âgés que chez les chiens plus jeunes. Les taux de CAV ne sont pas en relation avec l’age.

(Traduit par les auteurs)

PubMed Disclaimer

Figures

Figure 1
Figure 1
Antibody titer against CPV-2(a), CDV(b) and CAV-1(c) by age. Numbers in graph refer to number of dogs.
Figure 2
Figure 2
Tendency of antibody titer against CPV-2(a), CDV(b) and CAV-1(c) by age.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Lamm CG, Rezabek GB. Parvovirus infection in domestic companion animals. Vet Clin North Am Small Anim Pract. 2008;38:837–850. - PubMed
    1. Martella V, Elia G, Buonavoglia C. Canine distemper virus. Vet Clin North Am Small Anim Pract. 2008;38:787–797. - PubMed
    1. Decaro N, Martella V, Buonavoglia C. Canine adenoviruses and herpesvirus. Vet Clin North Am Small Anim Pract. 2008;38:799–814. - PMC - PubMed
    1. Eugster AK, Bendele RA, Jones LP. Parvovirus infection in dogs. J Am Vet Med Assoc. 1978;173:1340–1341. - PubMed
    1. Baba M, Yasoshima A, Kojima A, et al. Canine parvovirus infection in a group of beagles. Exp Anim. 1981;30:141–144. - PubMed

MeSH terms

Substances

LinkOut - more resources